Eric Lefebvre insider trades: Pliant Therapeutics (PLRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | PLRX | ↓ Sell10b5-1 | 18,478 | $11.20 | $207K | Direct | Jan 22, 2025 (5d) |
| Jul 10, 2024 | PLRX | ↓ Sell10b5-1 | 12,319 | $11.56 | $142K | Direct | Jul 12, 2024 (2d) |
| Jan 17, 2024 | PLRX | ↓ Sell10b5-1 | 10,295 | $17.23 | $177K | Direct | Jan 19, 2024 (2d) |
| Jul 17, 2023 | PLRX | ↓ Sell10b5-1 | 22,321 | $18.01 | $402K | Direct | Jul 19, 2023 (2d) |
| Mar 30, 2023 | PLRX | ↓ Sell10b5-1 | 11,245 | $26.52 | $298K | Direct | Apr 3, 2023 (4d) |
| Jan 23, 2023 | PLRX | ↓ Sell | 67,500 | $34.48 | $2.3M | Direct | Jan 25, 2023 (2d) |
| Dec 20, 2022 | PLRX | ↓ Sell | 10,887 | $19.10 | $208K | Direct | Dec 21, 2022 (1d) |
| Oct 25, 2022 | PLRX | ↓ Sell | 5,000 | $25.05 | $125K | Direct | Oct 27, 2022 (2d) |
| Jul 11, 2022 | PLRX | ↓ Sell | 3,000 | $20.00 | $60K | Direct | Jul 13, 2022 (2d) |
| Jun 18, 2021 | PLRX | ↓ Sell | 12,500 | $28.87 | $361K | Direct | Jun 22, 2021 (4d) |
| Mar 18, 2021 | PLRX | ↓ Sell | 12,500 | $39.41 | $493K | Direct | Mar 19, 2021 (1d) |
| Dec 18, 2020 | PLRX | ↓ Sell | 12,500 | $26.54 | $332K | Direct | Dec 21, 2020 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLRX insiders
Open-market trades in the last 12 months
About Eric Lefebvre's insider trades
Eric Lefebvre is Chief Medical Officer at Pliant Therapeutics (PLRX). Since Dec 18, 2020, Eric has reported no open-market purchases and 12 sales worth $5.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
5 sales (24% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (15 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.